Natasha B. Hunter, MD

Physician
Seattle Cancer Care Alliance
Assistant Professor, Division of Medical Oncology
University of Washington School of Medicine
Affiliate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Specialty:
Medical Oncology
“A cancer diagnosis changes people. It's rewarding to be present with them while they make that adjustment.”
— Dr. Hunter
Why did you change careers from journalism to medicine?

Medicine is similar to journalism in many ways: You read, you talk to experts, you observe, you listen to people's experiences and then you draw conclusions and write a summary. But, as a journalist, your goal is simply to tell the truth. This goal can place you at odds with your sources, and it can sometimes feel a bit abstract. In medicine, I love that I still get to do almost everything I enjoyed as a journalist, but now it’s always in pursuit of tangible goals around caring for people — goals that are shared among patients and providers.

Hunter-secondary.jpg
Why do you choose to work with patients who have breast cancer?

In my first year of fellowship, I met an elderly woman with metastatic breast cancer. She was in terrible shape, and I didn’t expect her to live very long, but she became my patient and lived for more than two years longer. Working with her made me understand the impact I can have on patients, especially those with breast cancer. We have more and more tools each day to treat this disease. I was inspired by her strength and felt very honored to care for her; that’s one of the reasons I chose this disease type.

Provider background

Specialty: Medical Oncology

Breast cancer

I am a board-certified medical oncologist who specializes in the treatment of breast cancer. Prior to joining SCCA, I completed a fellowship in oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Medicine. My research interests include studying breast cancer biomarkers, which may improve our ability to gauge response to treatment and monitor for recurrence and remission. I’m also interested in exploring new therapies for metastatic disease and how to improve access to studies and new treatments for patients who live in remote areas.

Diseases treated

Education, experience and certifications
Undergraduate Degree
University of Massachusetts, Amherst
Medical Degree
Warren Alpert Medical School at Brown University
Residency
Beth Israel Deaconess Medical Center
Fellowship
Johns Hopkins Hospital
Board Certification
Internal Medicine, 2015; Medical Oncology, 2018, American Board of Internal Medicine
Languages
English

Research

Clinical trials

We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.

Study ID:
Complete title
The Experience of SCCA Patients Living With Metastatic Breast Cancer
Study ID:
NCT04072952
A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (mBC)
Complete title
A Phase 1/2, open-label, dose escalation, and cohort expansion clinical trial to evaluate the safety, tolerability, and pharmacokinetics of ARV-471 in patients with ER+/HER2- locally advanced or metastatic breast cancer, who have received prior hormonal therapy and chemotherapy in the locally advanced/metastatic setting
Study ID:
NCT04395508
An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic
Complete title
AN EXPANDED ACCESS, SINGLE-ARM, MULTICENTER STUDY TO PROVIDE AT HOME SUBCUTANEOUS ADMINISTRATION OF PERTUZUMAB AND TRASTUZUMAB FIXED-DOSE COMBINATION (PH FDC SC) FOR PATIENTS WITH HER2-POSITIVE BREAST CANCER DURING THE COVID-19 PANDEMIC

Publications

Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.

Press

SCCA providers are often asked to give their medical expertise for press and news publications. Read articles by or about this SCCA provider.

‘I Have Metastatic Breast Cancer: What Are My Treatment Options?’

SCCA's Natasha B. Hunter, MD, spoke with Patient Power about treatment options for metastatic breast cancer. 

Your care team

At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Kelly A. Nelson, ARNP, DNP
Kelly A. Nelson, ARNP, DNP
Advanced Registered Nurse Practitioner
Advanced Practice Provider
Registered nurse (RN)
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and treatments.
Team coordinator (TC)
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.

Insurance

SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.

For providers